NCT03744104View on ClinicalTrials.gov

A Clinical Trial of A Quadrivalent Influenza Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

2,688

Participants

Timeline

Start Date

October 11, 2018

Primary Completion Date

October 8, 2019

Study Completion Date

October 8, 2019

Conditions
Influenza
Interventions
BIOLOGICAL

Quadrivalent influenza vaccine

0.5 mL, intramuscular, one dose

BIOLOGICAL

Trivalent influenza vaccine A

0.5 mL, intramuscular, one dose

BIOLOGICAL

Trivalent influenza vaccine B

0.5 mL, intramuscular, one dose

Trial Locations (2)

Unknown

Suining County Center for Disease Control and Prevention, Xuzhou

Xinyi County Center for Disease Control and Prevention, Xuzhou

All Listed Sponsors
lead

Shanghai Institute Of Biological Products

INDUSTRY

NCT03744104 - A Clinical Trial of A Quadrivalent Influenza Vaccine | Biotech Hunter | Biotech Hunter